What is the share price of KOBO Biotech Ltd (KOBO) today?
The share price of KOBO as on 17th April 2025 is ₹2.96. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on KOBO Biotech Ltd (KOBO) share?
The past returns of KOBO Biotech Ltd (KOBO) share are- Past 1 week: 1.37%
- Past 1 month: 9.63%
- Past 3 months: -24.68%
- Past 6 months: -0.34%
- Past 1 year: -27.80%
- Past 3 years: -52.10%
- Past 5 years: 26.50%
What are the peers or stocks similar to KOBO Biotech Ltd (KOBO)?
The peers or stocks similar to KOBO Biotech Ltd (KOBO) include:What is the market cap of KOBO Biotech Ltd (KOBO) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of KOBO Biotech Ltd (KOBO) is ₹7.05 Cr as of 17th April 2025.What is the 52 week high and low of KOBO Biotech Ltd (KOBO) share?
The 52-week high of KOBO Biotech Ltd (KOBO) is ₹5.11 and the 52-week low is ₹2.51.What is the PE and PB ratio of KOBO Biotech Ltd (KOBO) stock?
The P/E (price-to-earnings) ratio of KOBO Biotech Ltd (KOBO) is -1.43. The P/B (price-to-book) ratio is -0.06.Which sector does KOBO Biotech Ltd (KOBO) belong to?
KOBO Biotech Ltd (KOBO) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy KOBO Biotech Ltd (KOBO) shares?
You can directly buy KOBO Biotech Ltd (KOBO) shares on Tickertape. Simply sign up, connect your demat account and place your order.
KOBO Biotech Ltd
KOBO Share Price
2.964.96% (+0.14)
KOBO Share Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
KOBO Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -1.40 | -0.06 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 49.51 | 6.30 | 0.54% |
KOBO Analyst Ratings & Forecast
Detailed Forecast —
Forecast data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
KOBO Company Profile
Kobo Biotech Limited is an India-based company focused on manufacturing active pharmaceutical ingredients (APIs) and bulk drugs, currently undergoing corporate insolvency resolution.
KOBO Similar Stocks (Peers)
Compare with peersSUNPHARMA
PE Ratio
43.88
1Y Return
15.50%
Buy Reco %
88.24
CIPLA
PE Ratio
29.69
1Y Return
12.46%
Buy Reco %
72.73
TORNTPHARM
PE Ratio
66.50
1Y Return
27.80%
Buy Reco %
68.00
MANKIND
PE Ratio
55.68
1Y Return
7.76%
Buy Reco %
81.25
DRREDDY
PE Ratio
17.38
1Y Return
2.34%
Buy Reco %
45.16
KOBO Forecasts
Price
Revenue
Earnings
KOBO Share Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeKOBO Company Revenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeKOBO Stock EPS (Earnings Per Share) Forecast
Hmm, looks like data is unavailable here. Please come back after some timeKOBO
Income
Balance Sheet
Cash Flow
Annual Normal View
KOBO Income Statement
Annual Normal View
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 32.96 | 6.00 | 0.04 | 0.03 | 0.03 | 0.04 | 0.02 | 0.02 | 0.02 | 0.02 | ||||||||||
Raw Materials | 11.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.87 | 0.99 | ||||||||||
| Power & Fuel Cost | 2.03 | 0.28 | 0.24 | 0.31 | 0.42 | 0.28 | 0.10 | 0.12 | ||||||||||||
| Employee Cost | 4.27 | 3.11 | 2.42 | 2.08 | 1.80 | 1.39 | 0.72 | 0.23 | ||||||||||||
| Selling & Administrative Expenses | 0.96 | 0.16 | 0.11 | 0.21 | 0.14 | 0.15 | 0.11 | 0.14 | ||||||||||||
| Operating & Other expenses | 9.37 | 0.49 | 0.25 | 1.30 | -1.67 | 0.97 | 9.57 | 1.01 | ||||||||||||
EBITDA | 5.23 | 1.96 | -2.98 | -3.87 | -0.66 | -2.75 | -10.48 | -1.48 | -0.85 | -0.97 | ||||||||||
| Depreciation/Amortization | 7.31 | 6.78 | 6.44 | 6.15 | 5.88 | 5.64 | 4.61 | 4.07 | 4.07 | 4.07 | ||||||||||
| PBIT | -2.08 | -4.82 | -9.42 | -10.02 | -6.54 | -8.39 | -15.09 | -5.55 | -4.92 | -5.04 | ||||||||||
| Interest & Other Items | 14.37 | 14.41 | 14.50 | 14.44 | 14.47 | 10.84 | 0.13 | 0.00 | 0.00 | — | ||||||||||
| PBT | -16.45 | -19.23 | -23.92 | -24.46 | -21.01 | -19.23 | -15.22 | -5.55 | -4.92 | -5.04 | ||||||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| Net Income | -16.45 | -19.23 | -23.92 | -24.46 | -21.01 | -19.23 | -15.22 | -5.55 | -4.92 | -5.04 | ||||||||||
| EPS | -7.12 | -8.09 | -10.04 | -10.27 | -8.82 | -8.07 | -6.39 | -2.33 | -2.07 | -2.12 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
KOBO Company Updates
FY 2014
Annual report
PDFFY 2015
Annual report
PDFFY 2016
Annual report
PDFFY 2017
Annual report
PDFFY 2018
Annual report
PDFFY 2019
Annual report
PDFFY 2020
Annual report
PDFFY 2021
Annual report
PDFFY 2022
Annual report
PDFFY 2023
Annual report
PDFKOBO Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| KOBO Biotech Ltd | -1.43 | -0.06 | — |
| Sun Pharmaceutical Industries Ltd | 43.88 | 6.26 | 0.77% |
| Cipla Ltd | 29.69 | 4.57 | 0.86% |
| Torrent Pharmaceuticals Ltd | 66.50 | 16.07 | 0.86% |
KOBO Stock Price Comparison
Compare KOBO with any stock or ETFCompare KOBO with any stock or ETF
KOBO
KOBO Shareholdings
KOBO Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
KOBO Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
KOBO Shareholding Pattern
KOBO Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing KOBO stock
Looks like this stock is not in any smallcase yet.
KOBO Events
KOBO Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
KOBO has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
KOBO Upcoming Dividends
No upcoming dividends are available
KOBO Past Dividends
Cash Dividend
Ex DateEx DateSep 21, 2012
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Sep 21, 2012
Cash Dividend
Ex DateEx DateJul 22, 2011
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Jul 22, 2011
KOBO Stock News & Opinions
Articles & Videos
Earnings
Kobo Biotech reports standalone net loss of Rs 1.33 crore in the June 2024 quarter
Net Loss of Kobo Biotech reported to Rs 1.33 crore in the quarter ended June 2024 as against net loss of Rs 1.23 crore during the previous quarter ended June 2023. There were no Sales reported in the quarter ended June 2024 and during the previous quarter ended June 2023.Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Kobo Biotech to discuss results
Kobo Biotech will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live
8 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of -7.79%, vs industry avg of 9.04%
Over the last 5 years, market share stayed at 0%